Aasems Jacob, MD | Authors

Articles

Optimal Use of Bone-Targeted Agents in Breast Cancer

August 15, 2016

It is quite obvious that bone morbidity has a negative impact on our patients with breast cancer. The use of bone-modifying agents in this setting can yield significant quality-of-life benefits.